Evaluation of efficacy and safety of active vitamin D treatment for secondary hyperparathyroidism in patients on maintenance hemodialysis; competitive study
Not Applicable
- Conditions
- secondary hyperparathyroidism(SHPT)
- Registration Number
- JPRN-UMIN000001656
- Lead Sponsor
- Division of Nephrology Department of Medicine Showa University School of Medicin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Malignancy,malnutrition, active inflammatory or infectious disease 2)Severe heart failure and liver dysfunction 3)Pregnancy, during breast-feeding 4)Patients with allergy to affacalcidol and maxacalcitol 5)Primary hyperparathyroidism patients 6)Aluminum and Fe associated bone disease patients 7)Post parathyroidectomy patients, patients received percutaneous ethanol or vitamin D injection 8) Judged inappropriate for this study by the physicians 9)Parients who were recruited another clinical trial within 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The percentage achievement of recommendation value (60-180pg/mL) of intact parathyroid hormone(PTH).
- Secondary Outcome Measures
Name Time Method